News

The standard of care for managing patients with type 2 diabetes and CKD -- in addition to a healthy lifestyle -- has always ...
New data from the CONFIDENCE trial demonstrates that combination therapy with finerenone and empagliflozin leads to ...
A genetic mutation that fuses two genes drives several different cancer types by forming networks of protein interactions that alter gene expression in cells, a study by UT Southwestern Medical Center ...
Patients with diabetic kidney disease (DKD) and anemia have no worse, and possibly better, cardiovascular outcomes from finerenone treatment.
Hypertension, a global health crisis affecting over a billion adults, significantly elevates the risk of stroke, aneurysm, ...
Early detection and new biomarkers are changing how we manage acute kidney injury—and its link to chronic kidney disease.
Our “CATCH 5 in 5” initiative (Collaborative Actions Toward Community Health), aims to add five years to the lives of our ...
The renal function test market will expand significantly during the upcoming ten years due to anticipated growth of diagnostic tests designed for kidney function evaluation. Market analysts forecast ...
A recent study reveals that blood type incompatibility is a significant barrier for kidney transplants in India, with 87% of ...